Cargando…
Hepatitis B virus reactivation risk varies with different chemotherapy regimens commonly used in solid tumours
BACKGROUND: Hepatitis B virus (HBV) reactivation may occur with chemotherapy and has significant morbidity and mortality. The United States Centre for Disease Control and Prevention recommends pre-chemotherapy hepatitis B screening for all cancer patients, while the American Society of Clinical Onco...
Autores principales: | Ling, W H Y, Soe, P P, Pang, A S L, Lee, S-C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3670504/ https://www.ncbi.nlm.nih.gov/pubmed/23652302 http://dx.doi.org/10.1038/bjc.2013.225 |
Ejemplares similares
-
Risk of Liver Fibrosis in Hepatitis B Virus and HIV Coinfected Youths Receiving Tenofovir-Containing Antiretroviral Regimen
por: Aurpibul, Linda, et al.
Publicado: (2019) -
Targeting the YAP/TAZ mechanotransducers in solid tumour therapeutics
por: Gargalionis, Antonios N., et al.
Publicado: (2023) -
Determination of an optimal dosing regimen for aspirin chemoprevention of 1,2-dimethylhydrazine-induced colon tumours in rats
por: Barnes, C J, et al.
Publicado: (1999) -
Microsatellites in varied arenas of research
por: Remya, K. S., et al.
Publicado: (2010) -
Fetal growth and the risk of childhood non-CNS solid tumours in Western Australia
por: Laurvick, C L, et al.
Publicado: (2008)